Molecular Provides Update of European & Japanese Filings of Abicipar Pegol
20 Jul 2020 //
MOLECULARPARTNERS
The FDA Does Not Approve Allergan’s Wet AMD Drug Candidate Abicipar Pegol
29 Jun 2020 //
EYEWIRE
Allergan,AbbVie Company, & Molecular Partners Receive Letter Abicipar pegol
26 Jun 2020 //
PRNEWSWIRE
Molecular Partners`s AbbVie-partnered eye drug gets FDA safety snub
26 Jun 2020 //
REUTERS
Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies
15 Oct 2019 //
BIOSPACE
Allergan & Molecular Partners Announce Result from MAPLE study of Abicipar pegol
02 Apr 2019 //
PR NEWSWIRE
Abicipar Data: Potential to be the First Fixed 12-week Anti-VEGF Therapeutic
29 Oct 2018 //
YAHOO FINANCE